Add like
Add dislike
Add to saved papers

Serial C reactive protein values predict sensitivity of organisms to empirical antibiotics in neonates: a nested case-control study.

BACKGROUND: It is common clinical practice to repeat serum C reactive protein (CRP) estimation in the first 48 h after starting empirical antibiotics for neonatal sepsis. The change in CRP is believed to indicate whether the empirical antibiotics are appropriate or not, but there is little evidence to support this practice.

METHODS: This was a nested case-control study on neonates with suspected sepsis (clinical signs+baseline CRP >10 mg/L). We drew samples for serum CRP at baseline and at 24, 36 and 48 h after starting empirical antibiotics and stored them at -20°C. Those with positive blood cultures were enrolled into two groups: those who had received empirical antibiotics to which the organism was sensitive ('sensitive') and those who had received antibiotics to which the organism was resistant ('resistant'). Stored samples of these subjects were assayed for CRP. Repeated CRP values were compared between groups by mixed linear models. We evaluated change in CRP from baseline as a diagnostic test for identifying empirical use of sensitive antibiotics.

RESULTS: We enrolled 45 and 44 subjects in 'sensitive' and 'resistant' groups, respectively. In the 'resistant' group, median CRP increased with time but decreased in the 'sensitive' group. Decline in CRP by 48 h identified the use of antibiotics to which the organism was sensitive with 89% sensitivity and 80% specificity.

CONCLUSIONS: Serial CRP values in the first 48 h of antibiotic therapy help to predict whether the causative organism is sensitive to the empirical antibiotics administered.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app